Rate My Professor Andrei Drabovich

Drabovich's academic interests include proteomics, mass spectrometry, bioanalytical chemistry, cancer diagnostics, male infertility, and infectious disease diagnostics. His laboratory develops mass spectrometry-based immunoaffinity assays for biomarker discovery, validation, and serological diagnostics, targeting prostate cancer, male reproductive disorders, and viruses such as SARS-CoV-2. Key publications feature the identification of TEX101 and ECM1 biomarkers for azoospermia differential diagnosis in seminal plasma (Science Translational Medicine, 2013), germ cell-specific proteins AKAP4 and ACRV1 for viable sperm detection in non-obstructive azoospermia patients (Molecular & Cellular Proteomics, 2023), and a review on seminal plasma as a diagnostic fluid for male reproductive system disorders (Nature Reviews Urology, 2014). Additional works include rational design of SARS-CoV-2 serological diagnostics (Analytical Chemistry, 2022) and multi-omics analysis revealing protein-glutamine gamma-glutamyltransferase 4 elevation in prostate cancer patients (Molecular & Cellular Proteomics, 2019). Earlier contributions advanced non-SELEX aptamer selection using nonequilibrium capillary electrophoresis (Journal of the American Chemical Society, 2005; Nature Protocols, 2006). Drabovich teaches Advanced Mass Spectrometry courses LABMP 561 and MLSCI 461 and supervises undergraduate and graduate students. He has secured funding for serology diagnostics standardization and pandemic preparedness projects.